Skystar Bio-pharmaceutical Co. (fka SKBI)

[236T568]

huh?

so are you saying that failure to file the 2014 10k, failure to file the 2015 Q1 10Q, failure to file the 2015 Q2 10Q, providing fraudulent bank statements to the auditor, $24 million in A/R that were never collected and failure to find $16 million in cash are minor?

I never suggested that SKBI is a good investment. But the way Nasdaq handles some of these cases, they simply bend the rules whenever they can. At one point they delisted a company because they didn't have a viable business, according to Nasdaq. So now we have an exchange operator deciding which companies have a viable business. They sure as hell went outside the rules when they delisted ABAT. And then there is the case of that cleantech company where the SEC had to revert their delisting decision, after they delisted the company.